Using Telemedicine to Treat Opioid Use DisorderTHURSDAY, OCTOBER 11, 2018
To combat limited access to medication-assisted treatment (MAT) of opioid use disorder (OUD) in rural areas, the Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS) has developed Telemedicine and Prescribing Buprenorphine for the Treatment of Opioid Use Disorder to help clarify how clinicians can use telemedicine as a tool to expand buprenorphine-based MAT for OUD treatment under current DEA regulations. This guidance includes a clinical case example.
Recent News & Events
All-hazards Risk Assessment Toolkit
99999989The Healthcare and Public Health (HPH) Risk Identification and Site Criticality (RISC) Toolkit
CDC and CMS Free Long Term Care Infection Preventionist Training
99999989The Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and...
IHI Launches Better Maternal Outcomes Rapid Improvement Network
99999989The Institute for Healthcare Improvement (IHI) has launched a free six-month initiative...